{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Max Healthcare Institute Ltd
P/E at 64.1 vs Industry's 55.05: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 64.1 against an industry average of 55.05 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by nearly 8 percentage points, the three-month performance shows a less severe underperformance, signalling a complex momentum picture.
P/E at 64.10 vs Industry's 54.79: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 64.10 against an industry average of 54.79 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by a notable margin, the three-month performance tells a different story, highlighting a complex momentum shift in this large-cap hospital sector stock.
P/E at 65.08 vs Industry's 55.44: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 65.08 against an industry average of 55.44 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the stock’s rating was reassessed on 31 Oct 2025. While the one-year return trails the Sensex by a notable margin, the three-month performance tells a different story, revealing a complex momentum shift within the hospital sector.
Max Healthcare Institute Ltd is Rated Sell
Max Healthcare Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Max Healthcare Institute Sees Significant Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 10.46% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock remains close to its 52-week low, reflecting a complex interplay of bearish and bullish sentiments within the hospital sector.
P/E at 66.14 vs Industry's 56.45: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 66.14 against an industry average of 56.45 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. While the one-year return of -12.91% trails the Sensex’s -4.12%, the three-month performance shows a narrower underperformance, suggesting a complex momentum picture.
Max Healthcare Institute Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a significant 15.54% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock remains close to its 52-week low, reflecting a complex interplay of cautious optimism and sectoral headwinds.
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 13.02% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock remains close to its 52-week low and underperforms its sector, raising questions about the directional bets underpinning this spike in open interest.
Max Healthcare Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 11.11% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock remains close to its 52-week low and has underperformed its sector, raising questions about the underlying directional bets and broader market sentiment.
P/E at 64.64 vs Industry's 55.28: What the Data Shows for Max Healthcare Institute Ltd
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, continues to face headwinds amid a challenging market environment. Despite its significant benchmark status, the company’s recent downgrade to a Sell rating and its underperformance relative to the Sensex highlight the pressures confronting the healthcare industry and institutional investors alike.
Max Healthcare Institute Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 14.0% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock remains close to its 52-week low, reflecting a complex interplay of cautious optimism and sectoral headwinds in the hospital industry.
Max Healthcare Institute Sees Sharp Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 13.5% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock remains close to its 52-week low, reflecting a complex interplay of cautious optimism and underlying sector dynamics.
Max Healthcare Institute Sees Significant Open Interest Surge Amid Mixed Market Signals
Max Healthcare Institute Ltd (MAXHEALTH) has witnessed a notable 13.01% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock remains close to its 52-week low, reflecting a complex interplay of cautious optimism and underlying bearish sentiment within the hospital sector.
P/E at 63.45 vs Industry's 54.03: What the Data Shows for Max Healthcare Institute Ltd
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, has recently undergone a notable downgrade in its Mojo Grade from Hold to Sell as of 31 October 2025. This development comes amid a challenging performance backdrop and evolving institutional interest, underscoring the complexities of maintaining benchmark status in a competitive healthcare market.
P/E at 64.35 vs Industry's 55.37: What the Data Shows for Max Healthcare Institute Ltd
A price-to-earnings ratio of 64.35 against an industry average of 55.37 represents a significant premium for Max Healthcare Institute Ltd. Previously rated Hold by MarketsMOJO, the company’s rating was reassessed on 31 Oct 2025. The stock’s one-year return of -17.70% notably underperforms the Sensex’s -4.89%, while shorter-term losses have been less severe, signalling a complex performance dynamic.
Max Healthcare Declines 2.55%: Technical Weakness and Sector Pressure Weigh
Max Healthcare Institute Ltd’s shares fell by 2.55% over the week ending 20 Mar 2026, closing at ₹964.75 from ₹990.00 the previous Friday. This underperformance contrasted with the broader Sensex, which declined by a milder 0.28% during the same period. The stock faced persistent technical headwinds and sectoral pressures, culminating in a volatile week marked by sharp intraday moves and a notable intraday low on 19 Mar 2026.
Max Healthcare Institute Ltd Faces Challenges Amid Nifty 50 Membership and Institutional Shifts
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, has experienced notable headwinds in recent months. Despite its prestigious benchmark status, the company’s shares have underperformed the broader market, reflecting a complex interplay of valuation concerns, institutional holding adjustments, and sectoral pressures.
Max Healthcare Institute Ltd Hits Intraday Low Amid Price Pressure
Max Healthcare Institute Ltd experienced a notable decline today, touching an intraday low of Rs 950.1, reflecting a 3.0% drop as the stock faced significant price pressure amid broader sector and market weakness.
Max Healthcare Institute Ltd Faces Downward Pressure Amid Nifty 50 Membership and Institutional Shifts
Max Healthcare Institute Ltd, a prominent large-cap hospital sector stock and a constituent of the Nifty 50 index, has recently undergone a downgrade in its Mojo Grade from Hold to Sell as of 31 October 2025. This development comes amid a challenging performance trajectory and shifting institutional holdings, underscoring the complexities of maintaining benchmark status in a volatile market environment.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
